Training HIV Physicians to Prescribe Buprenorphine for Opioid Dependence
Authors:
- 1 October 2006
- journal article
- Published by SAGE Publications in Substance Abuse
- Vol. 27 (3) , 13-18
Abstract
Few HIV physicians are trained to provide buprenorphine treatment. We conducted a cross-sectional survey to assess the impact of an eight-hour course on the treatment of opioid dependence on HIV physicians’ preparedness to prescribe buprenorphine. One hundred thirteen of 257 trained physicians (44%) provided HIV care. Post-course, the majority of both HIV physicians and non-HIV physicians (66% vs. 67%, P =.8) planned to pursue a registration to prescribe buprenorphine. The most common reason for not planning to do so was lack of experience (9% vs. 15%, P =.19). Fifty-two of the 113 (46%) HIV physicians had concerns about prescribing buprenorphine. Thirty of the 52 (58%) indicated that interactions between buprenorphine and HAART was their primary concern. Following training, most physicians feel prepared and plan to obtain a registration to prescribe buprenorphine. HIV physicians’ concerns regarding interactions between buprenorphine and HAART need to be addressed in future training efforts.Keywords
This publication has 11 references indexed in Scilit:
- Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug UsersArchives of internal medicine (1960), 2005
- Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patientsJournal of General Internal Medicine, 2004
- From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United StatesDrug and Alcohol Dependence, 2003
- Providing Opioid Agonist Maintenance Therapy in a Generalist's Office: The Physician's PerspectiveSubstance Abuse, 2003
- The Physician's Role in Caring for Patients with Substance use Disorders: Implications for Medical Education and TrainingSubstance Abuse, 2002
- Methadone Maintenance in Primary CareJAMA, 2001
- Effect of Opioid Dependence Pharmacotherapies on Zidovudine DispositionThe American Journal on Addictions, 2001
- Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected personsJournal of General Internal Medicine, 2001
- Effect of Opioid Dependence Pharmacotherapies on Zidovudine DispositionThe American Journal on Addictions, 2001
- Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAARTDrug and Alcohol Dependence, 2000